Norway's Oil Fund to Abstain From Novo Nordisk Board Vote

Dow Jones

11/10

By Dominic Chopping

Norway's sovereign-wealth fund will abstain from voting on new board members at Novo Nordisk's extraordinary shareholders' meeting later this week.

Danish drugmaker Novo Nordisk said last month it will replace its chairman and other board members after its controlling shareholder pushed for more changes to revive the company's success in the weight-loss market.

Chairman Helge Lund, Vice Chair Henrik Poulsen and five independent directors are being replaced and an extraordinary general meeting held on Friday to vote on new board members.

The company's majority shareholder, the Novo Nordisk Foundation, is proposing new members for election, including former Novo Nordisk Chief Executive Lars Rebien Sorensen as chair and Cees de Jong as vice chair.

The Norwegian wealth fund, commonly known as the oil fund, said Monday that it will abstain from voting on the new board appointments, including the chair and vice chair. It didn't provide a reason for the decision.

The oil fund holds a 1.79% stake in Novo Nordisk, valued at around $5.54 billion at June 30.

Write to Dominic Chopping at dominic.chopping@wsj.com

(END) Dow Jones Newswires

November 10, 2025 03:29 ET (08:29 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2582752823"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2582752823\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2582752823?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-10 16:29","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2582752823","market":"hk","top_or_hot":-1,"title":"Norway's Oil Fund to Abstain From Novo Nordisk Board Vote","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Dominic Chopping \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Norway's sovereign-wealth fund will abstain from voting on new board members at <a href=\"https://laohu8.com/S/NVO\">Novo Nordisk</a>'s extraordinary shareholders' meeting later this week. \n</p>\n<p>\n  Danish drugmaker Novo Nordisk said last month it will replace its chairman and other board members after its controlling shareholder pushed for more changes to revive the company's success in the weight-loss market. \n</p>\n<p>\n  Chairman Helge Lund, Vice Chair Henrik Poulsen and five independent directors are being replaced and an extraordinary general meeting held on Friday to vote on new board members. \n</p>\n<p>\n  The company's majority shareholder, the Novo Nordisk Foundation, is proposing new members for election, including former Novo Nordisk Chief Executive Lars Rebien Sorensen as chair and Cees de Jong as vice chair. \n</p>\n<p>\n  The Norwegian wealth fund, commonly known as the oil fund, said Monday that it will abstain from voting on the new board appointments, including the chair and vice chair. It didn't provide a reason for the decision. \n</p>\n<p>\n  The oil fund holds a 1.79% stake in Novo Nordisk, valued at around $5.54 billion at June 30. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Dominic Chopping at dominic.chopping@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 10, 2025 03:29 ET (08:29 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Norway's Oil Fund to Abstain From Novo Nordisk Board Vote</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNorway's Oil Fund to Abstain From Novo Nordisk Board Vote\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2025-11-10 16:29</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Dominic Chopping \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Norway's sovereign-wealth fund will abstain from voting on new board members at <a href=\"https://laohu8.com/S/NVO\">Novo Nordisk</a>'s extraordinary shareholders' meeting later this week. \n</p>\n<p>\n  Danish drugmaker Novo Nordisk said last month it will replace its chairman and other board members after its controlling shareholder pushed for more changes to revive the company's success in the weight-loss market. \n</p>\n<p>\n  Chairman Helge Lund, Vice Chair Henrik Poulsen and five independent directors are being replaced and an extraordinary general meeting held on Friday to vote on new board members. \n</p>\n<p>\n  The company's majority shareholder, the Novo Nordisk Foundation, is proposing new members for election, including former Novo Nordisk Chief Executive Lars Rebien Sorensen as chair and Cees de Jong as vice chair. \n</p>\n<p>\n  The Norwegian wealth fund, commonly known as the oil fund, said Monday that it will abstain from voting on the new board appointments, including the chair and vice chair. It didn't provide a reason for the decision. \n</p>\n<p>\n  The oil fund holds a 1.79% stake in Novo Nordisk, valued at around $5.54 billion at June 30. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Dominic Chopping at dominic.chopping@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 10, 2025 03:29 ET (08:29 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NVO","symbol_name":"諾和諾德","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2582752823","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2582752823","pubTimestamp":1762763340,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Norway's sovereign-wealth fund will abstain from voting on new board members at Novo Nordisk's extraordinary shareholders' meeting later this week.Danish drugmaker Novo Nordisk said last month it will replace its chairman and other board members after its controlling shareholder pushed for more changes to revive the company's success in the weight-loss market.Chairman Helge Lund, Vice Chair Henrik Poulsen and five independent directors are being replaced and an extraordinary general meeting held on Friday to vote on new board members.The company's majority shareholder, the Novo Nordisk Foundation, is proposing new members for election, including former Novo Nordisk Chief Executive Lars Rebien Sorensen as chair and Cees de Jong as vice chair.The Norwegian wealth fund, commonly known as the oil fund, said Monday that it will abstain from voting on the new board appointments, including the chair and vice chair. It didn't provide a reason for the decision.The oil fund holds a 1.79% stake i","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"NVO":"诺和诺德","LU1093756168.USD":"FRANKLIN K2 ALTERNATIVE STRATEGIES \"A\" (USD) ACC","BK4588":"碎股","BK4585":"ETF&股票定投概念","IE00BKVL7J92.USD":"Legg Mason ClearBridge - US Equity Sustainability Leaders A Acc USD","IE00BZ1G4Q59.USD":"LEGG MASON CLEARBRIDGE US EQUITY SUSTAINABILITY LEADER \"A\"(USD) INC (A)","BK4532":"文艺复兴科技持仓","LU0154236417.USD":"BGF US FLEXIBLE EQUITY \"A2\" ACC","BK4599":"减肥药","LU1093756325.SGD":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1","BK4007":"制药"},"translate_title":"挪威石油基金将在诺和诺德董事会投票中弃权","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NVO":1.5},"content_text":"By Dominic Chopping \n\n\n \n\n\n  Norway's sovereign-wealth fund will abstain from voting on new board members at Novo Nordisk's extraordinary shareholders' meeting later this week. \n\n\n  Danish drugmaker Novo Nordisk said last month it will replace its chairman and other board members after its controlling shareholder pushed for more changes to revive the company's success in the weight-loss market. \n\n\n  Chairman Helge Lund, Vice Chair Henrik Poulsen and five independent directors are being replaced and an extraordinary general meeting held on Friday to vote on new board members. \n\n\n  The company's majority shareholder, the Novo Nordisk Foundation, is proposing new members for election, including former Novo Nordisk Chief Executive Lars Rebien Sorensen as chair and Cees de Jong as vice chair. \n\n\n  The Norwegian wealth fund, commonly known as the oil fund, said Monday that it will abstain from voting on the new board appointments, including the chair and vice chair. It didn't provide a reason for the decision. \n\n\n  The oil fund holds a 1.79% stake in Novo Nordisk, valued at around $5.54 billion at June 30. \n\n\n \n\n\n  Write to Dominic Chopping at dominic.chopping@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 10, 2025 03:29 ET (08:29 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}